About SESAP 18 CME

All continuing medical Education (CME) credit for SESAP^® 18 must be claimed by October 16, 2025. SESAP 18 will be available online until December 31, 2025, when the edition will be retired.

SESAP 18 is intended for general surgeons. Upon completion of SESAP 18, participants should be able to:

• Compare their cognitive knowledge at the beginning of the program with evidence-based surgical content for self-assessment and guided learning,
• Achieve and demonstrate mastery of surgical content to reach predetermined standards across all categories,
• Pursue lifelong excellence in surgery,
• Apply newly acquired knowledge to surgical practice,
• Keep current with surgical advances.

To earn continuing medical education (CME) credit, participants must use the SESAP 18 CME Web version. SESAP 18 includes 665 questions across 9 categories, all of which must be completed to earn the maximum of 168 CME credits. Individuals who subscribe by selected categories can earn CME credit only for those categories. Credits assigned to each category are as follows:

Participants enrolled for CME credit will be asked to read each question, select an answer, and review the corresponding critique and preferred answer. Participants will test their mastery of the content just learned by answering the same questions in a scrambled fashion and must achieve a score of 80%. If the score is less than 80%, the participant will be asked to review only the incorrect questions and answer those questions again until a score of 80% is achieved. If a score of 80% correct is not achieved after the third attempt, the participant will be asked to start the entire section over again.

If a category has multiple parts, each part must be completed with a score of 80% to claim credit for the entire category. After achieving a score of 80% for each category, participants will be asked to complete an evaluation form and submit data to the ACS using the Internet. Upon successful submission, a CME certificate will be available to print. SESAP 18 is certified for credit through October 16, 2025.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirements of the American Board of Surgery’s Continuous Certification program.

Transmitting CME Credit to the American Board of Surgery

To ensure your SESAP 18 CME data are transmitted appropriately from the American College of Surgeons (ACS) to the American Board of Surgery (ABS), please, use the ACS MyCME Portal. You will need your ACS ID log-in. This will be your membership number or the ACS ID you received when you created your ACS account. If you need assistance with the ACS ID contact Log-in Help.

Step-by-Step Instructions to Access MyCME and Transmit Your CME Data

1. Log into MyCME.
2. Once logged in, you will see your name at the top right of the page.
3. Select the “Send CME Data” tab.
4. Select the “Specialty Board” option.
5. From the recipient drop-menu, select American Board of Surgery.
6. Select “I Agree.”
7. Enter your ABS ID.
8. Enter your month and day of birth.
9. Confirm that your email address is correct.
10. Enter the desired start and end dates for your CME data range and click “Get Select Dates.”
11. Review the transcript data to confirm it is correct.
12. Once satisfied with the “Send to ABS” criteria, click the “Yes” button.

After your CME credits are sent, you will see a confirmation page. After 24 hours, you can log into your ABS account to confirm the credits are in your ABS CME Repository.

For questions about the MyCME portal, contact mycme@facs.org. For questions regarding the ABS requirements, please contact ABS at cc@absurgery.org.

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and authors) has disclosed all financial relationships with any companies defined as “ineligible” by the ACCME:

• Ineligible Company: Defined by the ACCME as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.
• Financial Relationships: Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options, or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected. ACCME considers relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
• Conflict of Interest: Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of a commercial interest with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity. Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Planning Committee

John A. Weigelt, MD, DVM, FACS, MAMSE, Program Director (Nothing to disclose)

David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)

David A. Bull, MD, FACS (Nothing to disclose)

Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)

Jason B. Fleming, MD, FACS (Advisor—Glycosbio Food Services, Inc.; Advisor—Bio-Path Holdings, Inc.; Advisor—Natera; Advisor—Panther Therapeutics, Inc.)

Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)

Lorrie A. Langdale, MD, FACS, MAMSE (Nothing to disclose)

David J. Milia, MD, FACS (Nothing to disclose)

Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (Nothing to disclose)

John T. Paige, MD, FACS (Co-editor— Oxford University Press; Co-editor—Springer Nature; Principal Investigator—SGEA/IAMSE; Site Investigator—Acell Inc.)

Walter E. Pofahl II, MD, FACS (Nothing to disclose)

Travis P. Webb, MD, MHPE, FACS, MAMSE (Nothing to disclose)

Authors

John V. Agapian, MD, FACS, FCCM (Nothing to disclose)

David C. Borgstrom, MD, MBA, FACS (Nothing to disclose)

Tawnya L. Bowles, MD, FACS (Nothing to disclose)

David A. Bull, MD, FACS (Nothing to disclose)

Casey M. Calkins, MD, FACS (Nothing to disclose)

Jeremy W. Cannon, MD, SM, FACS (Author—UpToDate)

Jay J. Doucet, MD, MSc, FRCSC, FACS, RDMS (Nothing to disclose)

Dan Eisenberg, MD, MS, FACS, FASMBS (Nothing to disclose)

Mary E. Fallat, MD, FACS (Nothing to disclose)

Jason B. Fleming, MD, FACS (Advisor—Glycosbio Food Services, Inc.; Advisor—Bio-Path Holdings, Inc.; Advisor—Natera; Advisor—Panther Therapeutics, Inc.)

Charles M. Friel, MD, FACS, FASCRS (Nothing to disclose)

David A. Gerber, MD, FACS (Consultant—Medtronic, Inc.; Stock options—BiomedInnovations, LLC)

Uzer Khan, MD, MBBS, FACS (Nothing to disclose)

Richard P. M. Koehler, MD, FACS (Nothing to disclose)

Mary R. Kwaan, MD, FACS (Nothing to disclose)

Lorrie A. Langdale, MD, FACS, MAMSE (Nothing to disclose)

Sean J. Langenfeld, MD, FACS, FASCRS (Nothing to disclose)

Robert B. Lim, MD, FACS, FASMBS (Consultant—UpToDate)

Dana Lin, MD, FACS (Nothing to disclose)

Linda L. Maerz, MD, FACS, FCCM (Nothing to disclose)

David J. Milia, MD, FACS (Nothing to disclose)

Rachel Morris, MD, FACS (Nothing to disclose)

Lena M. Napolitano, MD, FACS, FCCP, MCCM, MAMSE (Nothing to disclose)

John T. Paige, MD, FACS, MAMSE (Co-editor— Oxford University Press; Co-editor—Springer Nature; Principal Investigator—SGEA/IAMSE; Site Investigator—Acell Inc.)

Sharla Gayle Patterson, MD, MBA, FACS (Speaker—Hologic; Certification Application Reviewer—American Society of Breast Surgeons)

Jasmeet S. Paul, MD, FACS (Nothing to disclose)

Tam N. Pham, MD, FACS (Nothing to disclose)

Walter E. Pofahl II, MD, FACS (Nothing to disclose)

Paul J. Schenarts, MD, FACS, MAMSE (Nothing to disclose)

David G. Sheldon, MD, FACS (Nothing to disclose)

Shayna L. Showalter, MD, FACS (Nothing to disclose)

Lance E. Stuke, MD, MPH, FACS (Nothing to disclose)

Jennifer Tseng, MD, FACS (Consultant—Castle Biosciences)

Kiran K. Turaga, MBBS, FACS (Nothing to disclose)

Daniel Vargo, MD, FACS (Nothing to disclose)

Travis P. Webb, MD, MHPE, FACS, MAMSE (Nothing to disclose)

John A. Weigelt, MD, DVM, FACS, MAMSE (Nothing to disclose)

Nicole Zern, MD, FACS (Nothing to disclose)

Consultants

Ajit K. Sachdeva, MD, FACS, FRCSC, FSACME, MAMSE (Nothing to disclose)

Patrice Gabler Blair, DrPH, MPH (Nothing to disclose)

Staff

Julia C. Dudek, MPH (Nothing to disclose)

Chrysa M. Cullather, MS (Nothing to disclose)

Katherine M. Greenock, MS (Nothing to disclose)

Surgeons interested in achieving higher levels of cognitive skills have the opportunity to earn Education Credits of Excellence offered by the ACS Division of Education and approved by the ACS Board of Regents. For each category, participants have an option for additional study to demonstrate a higher level of expertise in the content area. The Education Credits of Excellence are entirely optional and are designed to encourage further learning and challenge surgeons who want to pursue a higher level of achievement.

Royal College of Physicians and Surgeons of Canada Accreditation

Through an agreement between the American College of Surgeons and the Royal College of Physicians and Surgeons of Canada, MOC Program participants may record completed self-assessment programs or simulation activities developed and accredited by the American College of Surgeons in Section 3 of the Royal College’s MOC Program.